PEAPACK, N.J. — Greenstone announced Monday that the Food and Drug Administration had granted it approval on an authorized generic of C.P. Pharmaceuticals Interntational’s Zyvox (linezolid) oral suspension.
The drug is indicated as a treatment for bacterial infections, some skin infections or pneumonia. Greenstone will offer it 100 mg/5-mL per 150 mL reconstituted.